DB
BHVN icon

Dmitry Balyasny’s Biohaven BHVN Stock Holding History

Dmitry Balyasny’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Sell
1,879,734
-565,682
-23% -$6.09M 0.03% 572
2026
Q1 		$20.7M Buy
2,445,416
+854,362
+54% +$9.35M 0.03% 680
2025
Q4 		$18M Buy
1,591,054
+1,210,180
+318% +$15M 0.02% 768
2025
Q3 		$5.72M Buy
+380,874
New +$5.54M 0.01% 1310
2025
Q2 		– Sell
-87,367
Closed -$2.1M – 2836
2025
Q1 		$2.1M Buy
+87,367
New +$3.08M ﹤0.01% 1680
2024
Q1 		– Sell
-48,404
Closed -$2.07M – 2624
2023
Q4 		$2.07M Buy
+48,404
New +$1.51M ﹤0.01% 1443
2023
Q1 		– Sell
-176,446
Closed -$2.45M – 2663
2022
Q4 		$2.45M Buy
+176,446
New +$2.49M 0.01% 1338

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dmitry Balyasny's BHVN Position: Q2 2026 in Review

Dmitry Balyasny reduced its Biohaven (BHVN) stake by 23% in Q2 2026, selling an estimated $6.09M and leaving 1,879,734 shares worth $28M. The position accounts for 0.03% of the portfolio, ranked #572.

Dmitry Balyasny first reported a position in BHVN in Q4 2022 and has held it in 7 quarters since. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Dmitry Balyasny held 1,879,734 shares of Biohaven worth $28M as of Q2 2026.
  • Dmitry Balyasny sold 565,682 Biohaven shares in Q2 2026, an estimated $6.09M.
  • Biohaven made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #572 holding.
  • Dmitry Balyasny first reported a position in Biohaven in Q4 2022 and has held it in 7 quarters since.
  • 291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.